M9-9 Aptamer Details
ID# 9070
Structure
Chemistry
RNA
Target
CTLA-4
Category
Protein
Affinity (Kd)
10 nM
Length
0
Aptazyme
No
Sequence (3-char table code)
G
A
C
U/T
rGprGprGprAprGprAprGprAprGprAprGprGprAprAprGprAprGprGprGprAprUprAprGprGprCprCprGprAprCprGprUprGprCprCprGprCprAprAprCprUprUprCprAprAprCprCprCprUprGprCprAprCprAprAprCprCprAprAprUprCprCprGprCprCprCprAprUprAprAprCprCprCprAprAprGprGprUprCprGprAprUprAprGprUprAprCprGprGprAprUprCprCprCprCprCprCp
Molecular Weight: 941600 L/(mole·cm)
Extinction Coefficient: 941600 L/(mole·cm)
Binding Conditions / Buffer
y, flat-bottom MaxiSorb microtiter plates, Nalge Nunc International (Naperville, IL) were
coated with 90.9nM mCTLA-4/Fc in 0.05M carbonate-bicarbonate buffer pH 9.6 and incubated
for 3 hours at room temperature with agitation. Plates were washed 5 times with HEPES wash
buffer: 20mM HEPES pH 7.4, 0.15M NaCl, 2mM CaCl2, then blocked by addition of Super
Block, Pierce (Rockford, IL) 3 times followed by washing 5 times. Serial dilutions of
biotinylated Del 60 aptamer were done in HEPES binding buffer (HEPES wash buffer + 0.01%
BSA) then incubated in the wells for 15 minutes at 37o
C. Following one wash with HEPES
buffer, streptavidin-AP (Jackson ImmunoResearch, West Grove, PA) was prepared in HEPES
buffer then added to the wells and incubated for 15 minutes at room temperature. Excess
streptavidin-AP was removed by washing 3 times with HEPES buffer then alkaline phosphatase
substrate (Sigma, St. Louis, MO) was added.
Binding Temp: 37 °C°C
Refolding Protocol
If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Reference
Santulli-Marotto S, Nair SK, Rusconi C, Sullenger B, Gilboa E. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Res. 2003 Nov 1;63(21):7483-9. PMID: 14612549.
Request a Quote
Have your aptamer oligo synthesized by Aptagen.